comparemela.com

Latest Breaking News On - Kerry holford - Page 1 : comparemela.com

NOVARTIS AG : Berenberg remains Neutral - MarketScreener

Berenberg analyst Kerry Holford maintains his Neutral opinion on the stock. The target price is reviewed upwards from CHF 74 to CHF 77.

Kerry-holford

Eli Lilly (LLY) Q1 2024 Earnings Call Transcript

Eli Lilly (LLY) Q1 2024 Earnings Call Transcript

PFIZER INC : Berenberg remains Neutral -April 10, 2024 at 11:48 am EDT

In a research note published by Kerry Holford, Berenberg gives a Neutral rating to the stock. Previously set at USD 29, the target price is lowered to USD 27.

Kerry-holford
Markets

GSK : Berenberg gives a Buy rating -April 03, 2024 at 06:52 am EDT

Kerry Holford from Berenberg retains his positive opinion on the stock with a Buy rating. The target price is still set at GBX 1820.

Kerry-holford
Markets

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.